(Q33969819)

30 July 2017

1 reference

title

Recurrent hepatitis C after liver transplantation. (English)

1 reference

30 July 2017

main subject

liver transplantation

1 reference

1 reference

1 reference

Teixeira R

1

1 reference

30 July 2017

Pastacaldi S

series ordinal

2

1 reference

30 July 2017

Papatheodoridis GV

series ordinal

3

1 reference

30 July 2017

Burroughs AK

series ordinal

4

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Journal of Medical Virology

30 July 2017

published in

1 reference

30 July 2017

volume

61

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

443-454

1 reference

Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

The role of the host immune state in recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Impact of hepatitis G virus co-infection on the course of hepatitis C virus infection before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis C virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Persistence of HCV despite antibodies to both putative envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis C viral infection in the immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

A pilot study of ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Detection of hepatitis C after liver transplantation. Four serologic tests compared.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Reinfection of liver graft by hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Ribavirin therapy for hepatitis C infection following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

A longitudinal analysis of hepatitis C virus replication following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatocellular cholestasis: pathobiology and histological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Recurrence of hepatitis C virus infection after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Withdrawal of immunosuppression in liver allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Histological and clinical outcome after liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200008%2961%3A4%3C443%3A%3AAID-JMV6%3E3.0.CO%3B2-Z

10.1002/1096-9071(200008)61:4<443::AID-JMV6>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference